Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2777

1.

BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Cornillon J, Daguenet E, Bay JO, Chauchet A, Salles G, Contentin N, Nicolas-Virelizier E, Mercier M, Vallet N, Alexis M, Chrétien ML, Cluzeau T, Huynh A, Himberlin C, Dorvaux V, Amorim S, Lejeune C, de Latour RP, Gyan E.

Ann Hematol. 2019 Aug;98(8):1973-1980. doi: 10.1007/s00277-019-03704-z. Epub 2019 May 20.

PMID:
31111177
2.

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.

Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, Ma Z, Condori J, Dowdy J, Triplett B, Li C, Maron G, Aldave Becerra JC, Church JA, Dokmeci E, Love JT, da Matta Ain AC, van der Watt H, Tang X, Janssen W, Ryu BY, De Ravin SS, Weiss MJ, Youngblood B, Long-Boyle JR, Gottschalk S, Meagher MM, Malech HL, Puck JM, Cowan MJ, Sorrentino BP.

N Engl J Med. 2019 Apr 18;380(16):1525-1534. doi: 10.1056/NEJMoa1815408.

PMID:
30995372
3.

Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.

Hyung J, Hong JY, Yoon DH, Kim S, Park JS, Park CS, Lee SW, Kim JH, Ryu JS, Huh J, Suh C.

Ann Hematol. 2019 Jul;98(7):1657-1664. doi: 10.1007/s00277-019-03667-1. Epub 2019 Apr 15.

PMID:
30989325
4.

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.

Bashir Q, Thall PF, Milton DR, Fox PS, Kawedia JD, Kebriaei P, Shah N, Patel K, Andersson BS, Nieto YL, Valdez BC, Parmar S, Rondon G, Delgado R, Hosing C, Popat UR, Oran B, Ciurea SO, Lin P, Weber DM, Thomas SK, Lee HC, Manasanch EE, Orlowski RZ, Williams LA, Champlin RE, Qazilbash MH.

Lancet Haematol. 2019 May;6(5):e266-e275. doi: 10.1016/S2352-3026(19)30023-7. Epub 2019 Mar 22.

PMID:
30910541
5.

Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma.

Blanes M, Lorenzo JI, Ribas P, Jiménez A, González JD, Cejalvo MJ, Solano C, Alegre A, de la Rubia J.

Ann Hematol. 2019 Aug;98(8):2013-2015. doi: 10.1007/s00277-019-03663-5. Epub 2019 Mar 16. No abstract available.

PMID:
30879095
6.

Effects of Sertoli Cell Transplantation on Spermatogenesis in Azoospermic Mice.

Ziaeipour S, Ahrabi B, Naserzadeh P, Aliaghaei A, Sajadi E, Abbaszadeh HA, Amini A, Abdi S, Darabi S, Abdollahifar MA.

Cell Physiol Biochem. 2019;52(3):421-434. doi: 10.33594/000000030. Epub 2019 Mar 8.

7.

Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.

Youshani AS, Rowlston S, O'Leary C, Forte G, Parker H, Liao A, Telfer B, Williams K, Kamaly-Asl ID, Bigger BW.

J Neuroinflammation. 2019 Feb 5;16(1):25. doi: 10.1186/s12974-019-1410-y.

8.

PGAM1 knockdown is associated with busulfan‑induced hypospermatogenesis and spermatogenic cell apoptosis.

Zhao Y, Zhang S.

Mol Med Rep. 2019 Apr;19(4):2497-2502. doi: 10.3892/mmr.2019.9930. Epub 2019 Feb 4.

9.

Influence of temperature rise by 2.5°C on the increase of apoptosis of HL-60 cells treated with busulfan.

Sztafrowski D, Jaźwiec B, Kuliczkowski K.

Adv Clin Exp Med. 2019 May;28(5):581-585. doi: 10.17219/acem/91821.

10.

The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan.

Lee CC, Chang HH, Lu MY, Yang YL, Chou SW, Lin DT, Jou ST, Yao M, Li CC, Yeh SP, Chen MH, Gau JP, Li SS, Wang PN, Liu YC, Wang TF, Tan TD, Lee MY, Yu MS, Wang CC, Lin SC, Chen YC, Su YC, Su KY, Lin KH.

Ann Hematol. 2019 Mar;98(3):745-752. doi: 10.1007/s00277-019-03604-2. Epub 2019 Jan 21.

PMID:
30666432
11.

Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.

Huang H, Zhang L, Jiang Y, Liu S, Jin Z, Chen J, Xiao X, Ruan J, Zhang X, Wu D.

Ann Hematol. 2019 May;98(5):1259-1266. doi: 10.1007/s00277-018-3576-2. Epub 2019 Jan 12.

PMID:
30635767
12.

An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish.

Khan N, Mahajan NK, Sinha P, Jayandharan GR.

Blood Cells Mol Dis. 2019 Mar;75:48-55. doi: 10.1016/j.bcmd.2018.12.007. Epub 2018 Dec 30.

PMID:
30616104
13.

Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use.

Sagou K, Ukai S, Adachi Y, Fukushima N, Ozeki K, Kohno A.

Int J Hematol. 2019 Mar;109(3):299-308. doi: 10.1007/s12185-018-02581-y. Epub 2019 Jan 2.

PMID:
30604314
14.

The effects of human menstrual blood stem cells-derived granulosa cells on ovarian follicle formation in a rat model of premature ovarian failure.

Manshadi MD, Navid S, Hoshino Y, Daneshi E, Noory P, Abbasi M.

Microsc Res Tech. 2019 Jun;82(6):635-642. doi: 10.1002/jemt.23120. Epub 2018 Dec 23.

PMID:
30582244
15.

Development of Spermatogenesis In Vitro in Three-Dimensional Culture from Spermatogonial Cells of Busulfan-Treated Immature Mice.

AbuMadighem A, Solomon R, Stepanovsky A, Kapelushnik J, Shi Q, Meese E, Lunenfeld E, Huleihel M.

Int J Mol Sci. 2018 Nov 29;19(12). pii: E3804. doi: 10.3390/ijms19123804.

16.

Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model.

Mahmud N, Khanal A, Taioli S, Koca E, Gaitonde S, Petro B, Sweiss K, Halliday L, Wang X, Patel P, Rondelli D.

PLoS One. 2018 Nov 29;13(11):e0206980. doi: 10.1371/journal.pone.0206980. eCollection 2018.

17.

Pre-formulation investigations for establishing a protocol for treosulfan handling and activation.

El-Serafi I, Loy O, Zhao Y, Oerther S, Mattsson J.

Pharm Dev Technol. 2019 Jun;24(5):639-648. doi: 10.1080/10837450.2018.1551903. Epub 2019 Jan 10.

PMID:
30474459
18.

Co-transplantation of mesenchymal stem cells improves spermatogonial stem cell transplantation efficiency in mice.

Kadam P, Ntemou E, Baert Y, Van Laere S, Van Saen D, Goossens E.

Stem Cell Res Ther. 2018 Nov 21;9(1):317. doi: 10.1186/s13287-018-1065-0.

19.

Validation of Housekeeping Genes as Reference for Reverse-Transcription-qPCR Analysis in Busulfan-Injured Microvascular Endothelial Cells.

Ju W, Smith AO, Sun T, Zhao P, Jiang Y, Liu L, Zhang T, Qi K, Qiao J, Xu K, Zeng L.

Biomed Res Int. 2018 Oct 2;2018:4953806. doi: 10.1155/2018/4953806. eCollection 2018.

20.

A Single-Center Experience With Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: A Modest Pitch for Non-Total Body Irradiation Conditioning Regimens.

Hamidieh AA, Eslami Shahre Babaki A, Rostami T, Kasaeian A, Koochakzadeh L, Sharifi Aliabadi L, Behfar M, Ghavamzadeh A.

Exp Clin Transplant. 2019 Apr;17(2):243-250. doi: 10.6002/ect.2017.0226. Epub 2018 Oct 5.

Supplemental Content

Loading ...
Support Center